<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Molecular Therapeutic</title>
	<atom:link href="https://www.worldpharmatoday.com/topics/molecular-therapeutic/feed/" rel="self" type="application/rss+xml" />
	<link>https://www.worldpharmatoday.com</link>
	<description>Magazine for the C-level Pharma Executives</description>
	<lastBuildDate>Fri, 06 Feb 2026 10:30:02 +0000</lastBuildDate>
	<language>en-US</language>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	<generator>https://wordpress.org/?v=6.9.4</generator>

<image>
	<url>https://www.worldpharmatoday.com/wp-content/uploads/2025/12/cropped-World-Pharma-Today-fevicon-32x32.jpg</url>
	<title>Molecular Therapeutic</title>
	<link>https://www.worldpharmatoday.com</link>
	<width>32</width>
	<height>32</height>
</image> 
	<item>
		<title>Nanotechnology Applications in Drug Delivery Development</title>
		<link>https://www.worldpharmatoday.com/drug-research/nanotechnology-applications-in-drug-delivery-development/</link>
		
		<dc:creator><![CDATA[Yuvraj]]></dc:creator>
		<pubDate>Fri, 06 Feb 2026 10:30:02 +0000</pubDate>
				<category><![CDATA[Clinical Trials]]></category>
		<category><![CDATA[Drug Research]]></category>
		<category><![CDATA[Techno Trends]]></category>
		<category><![CDATA[Biopharmaceutical Development]]></category>
		<category><![CDATA[Findings]]></category>
		<category><![CDATA[Molecular Therapeutic]]></category>
		<category><![CDATA[Preclinical Examination]]></category>
		<category><![CDATA[Treatments]]></category>
		<guid isPermaLink="false">https://www.worldpharmatoday.com/uncategorized/nanotechnology-applications-in-drug-delivery-development/</guid>

					<description><![CDATA[<p>Investigation into the role of nanoscale carriers in enhancing therapeutic precision, overcoming biological barriers, and enabling the delivery of sensitive genetic materials.</p>
The post <a href="https://www.worldpharmatoday.com/drug-research/nanotechnology-applications-in-drug-delivery-development/">Nanotechnology Applications in Drug Delivery Development</a> first appeared on <a href="https://www.worldpharmatoday.com">World Pharma Today</a>.]]></description>
		
		
		
			</item>
		<item>
		<title>Advanced Drug Delivery Systems in Modern Therapeutics</title>
		<link>https://www.worldpharmatoday.com/drug-research/advanced-drug-delivery-systems-in-modern-therapeutics/</link>
		
		<dc:creator><![CDATA[Yuvraj]]></dc:creator>
		<pubDate>Fri, 06 Feb 2026 10:17:18 +0000</pubDate>
				<category><![CDATA[Clinical Trials]]></category>
		<category><![CDATA[Drug Research]]></category>
		<category><![CDATA[Production & Manufacturing]]></category>
		<category><![CDATA[Biopharmaceutical Development]]></category>
		<category><![CDATA[Molecular Therapeutic]]></category>
		<category><![CDATA[Pharmaceuticals]]></category>
		<guid isPermaLink="false">https://www.worldpharmatoday.com/uncategorized/advanced-drug-delivery-systems-in-modern-therapeutics/</guid>

					<description><![CDATA[<p>Exploration of how sophisticated delivery mechanisms enhance medical efficacy, reduce side effects, and enable personalized treatment across oncology, neurology, and chronic disease management.</p>
The post <a href="https://www.worldpharmatoday.com/drug-research/advanced-drug-delivery-systems-in-modern-therapeutics/">Advanced Drug Delivery Systems in Modern Therapeutics</a> first appeared on <a href="https://www.worldpharmatoday.com">World Pharma Today</a>.]]></description>
		
		
		
			</item>
		<item>
		<title>Regeneron Looks to Infusing More Funds into Gene Editing</title>
		<link>https://www.worldpharmatoday.com/news/regeneron-looks-to-infusing-more-funds-into-gene-editing/</link>
		
		<dc:creator><![CDATA[Yuvraj]]></dc:creator>
		<pubDate>Fri, 05 Dec 2025 07:32:44 +0000</pubDate>
				<category><![CDATA[Drug Research]]></category>
		<category><![CDATA[News]]></category>
		<category><![CDATA[Big Pharma]]></category>
		<category><![CDATA[Biopharmaceutical Development]]></category>
		<category><![CDATA[Molecular Therapeutic]]></category>
		<category><![CDATA[Treatments]]></category>
		<guid isPermaLink="false">https://www.worldpharmatoday.com/uncategorized/regeneron-looks-to-infusing-more-funds-into-gene-editing/</guid>

					<description><![CDATA[<p>Regeneron Pharmaceuticals is going ahead and investing more funds into gene editing, as it has announced a collaboration with Tessera Therapeutics in December 2025, so as to create an experimental program pertaining to rare liver and lung disease. At the core of this deal is a treatment that Tessera, a well-funded startup that is backed [&#8230;]</p>
The post <a href="https://www.worldpharmatoday.com/news/regeneron-looks-to-infusing-more-funds-into-gene-editing/">Regeneron Looks to Infusing More Funds into Gene Editing</a> first appeared on <a href="https://www.worldpharmatoday.com">World Pharma Today</a>.]]></description>
		
		
		
			</item>
		<item>
		<title>AI-Driven Small Molecule Therapies for I&#038;I Diseases</title>
		<link>https://www.worldpharmatoday.com/it-data-management/ai-driven-small-molecule-therapies-for-ii-diseases/</link>
		
		<dc:creator><![CDATA[Yuvraj]]></dc:creator>
		<pubDate>Tue, 11 Mar 2025 05:33:41 +0000</pubDate>
				<category><![CDATA[IT & Data Management]]></category>
		<category><![CDATA[Molecular Therapeutic]]></category>
		<guid isPermaLink="false">https://www.worldpharmatoday.com/uncategorized/ai-driven-small-molecule-therapies-for-ii-diseases/</guid>

					<description><![CDATA[<p>AI Advances Small Molecule Therapies for I&#38;I Diseases Driven by artificial intelligence, drug development is proceeding against incentives from the Inflation Reduction Act and also makes the small molecules all the more appealing in the complex inflammatory and immunological illness spectrum.  When it comes to immunological illnesses and chronic inflammation throughout the past three decades [&#8230;]</p>
The post <a href="https://www.worldpharmatoday.com/it-data-management/ai-driven-small-molecule-therapies-for-ii-diseases/">AI-Driven Small Molecule Therapies for I&I Diseases</a> first appeared on <a href="https://www.worldpharmatoday.com">World Pharma Today</a>.]]></description>
		
		
		
			</item>
	</channel>
</rss>
